Over this period, Pharmaceuticals shows 4 positive, 0 neutral and 0 negative news signals across its constituents. The auto-generated sector insight (top drivers with direction + rationale) appears here once the analysis worker has processed enough items.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
A cabinet body has approved prices for 52 new life-saving medicines, a DRAP pricing move that typically lets pharma makers resume or launch products previously stuck without a viable price.
Forty medicines have gone missing from Pakistani pharmacies because the drug regulator has not cleared new prices for them, a bottleneck that squeezes listed pharma makers even as it hurts patients.
A delayed DRAP decision on essential medicine prices is contributing to shortages, squeezing margins for pharma makers that carry regulated, low-margin product lines.
A backlog in DRAP's approval of hardship-case price increases is causing shortages of some essential medicines and squeezing margins on older, low-price product lines for branded pharma makers.
The recently passed FY27 budget reaffirms Pakistan's commitment to trade liberalisation, continuing tariff reforms that reduce import duties. This policy aims to lower input costs for industries reliant on imported raw materials, potentially benefiting several sectors.
The government is implementing a barcode system on all medicines within 60 days to combat fake drugs, while also hosting a Pak-China Pharma Conference to attract foreign investment and technology, both positive developments for the pharmaceutical sector.
A new report suggests Pakistan could save $340 million annually on crude oil imports if sanctions on Iran are lifted, potentially boosting bilateral trade to $10 billion and opening new markets for Pakistani exporters.
The Punjab government has spent over Rs 18.5 billion on free treatment under various health programs, with further initiatives planned. This increased government spending is expected to boost demand for pharmaceutical products, positively impacting local drug manufacturers.
Liven Pharma Limited has signed a memorandum of understanding with China's TOFFLON Science and Technology Group to enhance pharmaceutical and biotechnology manufacturing capabilities locally.
Liven Pharma Limited has announced a strategic partnership with China's TOFFLON Science and Technology Group, a global leader in pharmaceutical manufacturing technologies, through a Memorandum of Understanding.
Karachi's transport strike has ended after successful negotiations, bringing relief to commuters and businesses. This development is positive for companies relying on efficient logistics and distribution in the city, particularly in the fast-moving consumer goods, oil marketing, and pharmaceutical sectors.
The Pakistan Textile Council has praised the Finance Bill 2026-27 for abolishing super tax on exporters and rationalizing it for other companies, while also welcoming revised income tax slabs for salaried individuals.
The government has announced the removal of taxes on sanitary products and contraceptives in the latest budget, a move aimed at public welfare and potentially boosting demand for these essential items.
The federal government has increased the Benazir Income Support Programme (BISP) allocation by 17% to Rs838 billion for FY2026-27, a move expected to enhance consumer purchasing power, particularly for essential goods.
The federal government's proposal for a 7% increase in public sector salaries and pensions, alongside a 10% rise in the minimum wage for fiscal year 2026-27, is expected to enhance consumer purchasing power, positively impacting companies in consumer-facing sectors.
Pakistan has reduced tariffs on pharmaceutical inputs, a move designed to lower production costs for local drug manufacturers and encourage domestic drug production.
Showing 1–16 of 42
How news sentiment on the Pharmaceuticals sector has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
